Swana 2016.

Study characteristics
Methods	Trial design: CBA (called quasi‐experimental by study authors) Data collection: weekly CHW records, pre‐ and postintervention school malaria prevalence surveys (and qualitative studies) Length of follow‐up: 13 months
Participants	Target treatment group: all ages > 2 months Sample size: not known Exclusion criteria: pregnancy
Interventions	Staff who received training: CHWs Duration of training: 3 days Content of training: treating P falciparum malaria after positive mRDT with AQAS or rectal AS, and referring if negative mRDT as appropriate Supervision: initial observation of mRDTs by supervisors with corrective actions over 2–4 days, weekly visits thereafter, 3 monthly meetings with investigators Antimalarials free to participants: yes mRDTs free to participants: not reported Additional details: CHWs given bicycles (which they could keep) and food baskets at end of study. Community sensitization campaign at start and ongoing information sessions by CHWs. Periodic IRS and larval source management
Outcomes	Parasitaemia
Notes	Control: health facility care Country: Democratic Republic of the Congo Setting: rural Malaria endemicity: high prevalence, perennial Study dates: November 2011–August 2013 Study sponsor: Freeport McMoRan and Tenke Fungurume Mining, US President's Malaria Initiative
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	High risk	Not randomized, quasi‐experimental with 1 intervention and 1 comparison area.
Allocation concealment (selection bias)	High risk	Not randomized, quasi‐experimental with 1 intervention and 1 comparison area.
Selective reporting (reporting bias)	Low risk	None identified.
Other bias	Unclear risk	Few details, however net ownership/use was slightly higher in intervention regions, and malaria prevalence at the beginning of the study was significantly higher in the intervention arm compared to the comparison arm. Uptake of mRDTs was unclear.